TRAW

Conviction 4HealthcareScan · Thu, Jun 25, 2026

TRAW$0.8383-2.64%

ResistanceSupportVol 14Insider buy

Vol MA14 741.49K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Traws Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.trawspharma.com ↗

Price0.8383

Change-2.64%

Gap-0.70%

Rel volume1.20×

Avg volume610.13K

Avg $ vol598.8K

SMA 201.17

SMA 501.37

SMA 2001.85

Price vs 50-38.88%

Price vs 200-54.76%

MA stackbearish

50/200 cross—

Supertrenddown · 1.24

RSI (14)33

MACD hist-0.03

MACD cross—

Stoch %K / %D24 / 24

ADX (14)26

+DI / −DI17 / 34

RSI divergence—

MACD divergence—

ATR %+17.65%

ADR %10.56%

52w high3.13

52w low0.7558

From 52w high-73.22%

Above 52w low+10.92%

New 52w highNo

SqueezeOff

Bollinger width96.37%

%B0.21

Donchian pos21.79%

Donchian high1.55

Donchian low0.6400

AVWAP (52w high)2.02

vs AVWAP high-58.43%

AVWAP (52w low)0.8342

vs AVWAP low+0.49%

OBV trendDown

Chaikin MF (20)-0.22

Today vs 20d1.20×

Avg vol (14d)741.49K

Avg vol (20d)610.13K

Avg $ vol (20d)598.8K

Market cap12.7M

RS 3m (vs SPY)-72.21%

RS 6m (vs SPY)-40.21%

RS line new highNo

Trend template0/8

Technical rank6.6

1 week+4.98%

1 month-46.94%

3 months-58.08%

6 months-36.49%

1 year-45.21%

YTD-36.97%

P/E1.39

P/B1.10

P/S—

P/FCF-0.70

EPS0.8200

Div yield—

ROE79.23%

ROA112.43%

Debt/Eq—

Current0.43

EV/EBITDA0.44

Gross margin—

Net margin—

Rev growth—

EPS growth105.51%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-7.86M

Revenue57K

Net income-7.11M

Gross profit—

Free cash flow-18.2M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees7

ListedThu, Jul 25, 2013

Free float4.96M

Float %62.1%

Short interest1.38M

Days to cover1.9d

Short volume36.9%

Squeeze score53 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank6.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.59

Support0.6944

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TRAW

All disclosures →

No recent disclosed trades by Congress in TRAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TRAW · 8 buys

Insider	Side	Shares	Value	Traded	Filed
OrbiMed Capital GP VIII LLC 10% owner · Series B Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Series B Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
OrbiMed Capital GP VIII LLC 10% owner · Series A Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Series C Warrants (right to buy) · 2026-04-16	Buy	1.79M	—	2026-04-16	2026-04-28
OrbiMed Capital GP VIII LLC 10% owner · Common Stock · 2026-04-16	Buy	597.73K	$998K	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Series A Warrants (right to buy) · 2026-04-16	Buy	597.73K	—	2026-04-16	2026-04-28
OrbiMed Capital GP VIII LLC 10% owner · Series C Warrants (right to buy) · 2026-04-16	Buy	1.79M	—	2026-04-16	2026-04-28
ORBIMED ADVISORS LLC 10% owner · Common Stock · 2026-04-16	Buy	597.73K	$998K	2026-04-16	2026-04-28

SEC filings

EDGAR filings in TRAW · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.